Cohen V - Search Results

1

Molecularly targeted approaches to the chemoprevention of lung cancer.

Khuri FR, Cohen V. Khuri FR, et al. Among authors: cohen v. Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4249s-4253s. doi: 10.1158/1078-0432.CCR-040019. Clin Cancer Res. 2004. PMID: 15217968 Review.

2

Chemoprevention of lung cancer: current status and future prospects.

Cohen V, Khuri FR. Cohen V, et al. Cancer Metastasis Rev. 2002;21(3-4):349-62. doi: 10.1023/a:1021223313546. Cancer Metastasis Rev. 2002. PMID: 12549771 Review.

3

Progress in lung cancer chemoprevention.

Cohen V, Khuri FR. Cohen V, et al. Cancer Control. 2003 Jul-Aug;10(4):315-24. doi: 10.1177/107327480301000406. Cancer Control. 2003. PMID: 12915810 Free article. Review.

4

Chemoprevention of lung cancer.

Cohen V, Khuri FR. Cohen V, et al. Curr Opin Pulm Med. 2004 Jul;10(4):279-83. doi: 10.1097/01.mcp.0000129754.97392.d5. Curr Opin Pulm Med. 2004. PMID: 15220752 Review.

5

Chemoprevention of lung cancer: concepts and strategies.

Cohen V, Khuri FR. Cohen V, et al. Expert Rev Anticancer Ther. 2005 Jun;5(3):549-65. doi: 10.1586/14737140.5.3.549. Expert Rev Anticancer Ther. 2005. PMID: 16001960 Review.

6

Farnesyltransferase inhibitors: a promising future in cancer treatment.

Khuri FR, Cohen V. Khuri FR, et al. Among authors: cohen v. Clin Lung Cancer. 2002 Jul;4(1):63-4. doi: 10.1016/s1525-7304(11)70674-x. Clin Lung Cancer. 2002. PMID: 14653879 No abstract available.

7

Evaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancer.

Cohen V, Agulnik JS, Jarry J, Batist G, Small D, Kreisman H, Tejada NA, Miller WH Jr, Chong G. Cohen V, et al. Cancer. 2006 Dec 15;107(12):2858-65. doi: 10.1002/cncr.22331. Cancer. 2006. PMID: 17096434 Free article.

8

Epidermal growth factor receptor mutations detected by denaturing high-performance liquid chromatography in nonsmall cell lung cancer: impact on response to therapy with epidermal growth factor receptor-tyrosine kinase inhibitors.

Cohen V, Agulnik JS, Ang C, Kasymjanova G, Batist G, Small D, Brandao G, Chong G, Miller WH Jr. Cohen V, et al. Cancer. 2010 Sep 15;116(18):4309-17. doi: 10.1002/cncr.25214. Cancer. 2010. PMID: 20549828 Free article.

9

The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Center: A Retrospective Chart Review.

Kasymjanova G, Anwar A, Cohen V, Sultanem K, Pepe C, Sakr L, Friedmann J, Agulnik JS. Kasymjanova G, et al. Among authors: cohen v. Curr Oncol. 2021 Oct 20;28(6):4247-4255. doi: 10.3390/curroncol28060360. Curr Oncol. 2021. PMID: 34898542 Free PMC article.

10

High risk of deep vein thrombosis in patients with non-small cell lung cancer: a cohort study of 493 patients.

Tagalakis V, Levi D, Agulnik JS, Cohen V, Kasymjanova G, Small D. Tagalakis V, et al. Among authors: cohen v. J Thorac Oncol. 2007 Aug;2(8):729-34. doi: 10.1097/JTO.0b013e31811ea275. J Thorac Oncol. 2007. PMID: 17762339 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters